BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36503148)

  • 1. Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms.
    Sande CM; Wu R; Yang G; Sussman RT; Bigdeli A; Rushton C; Chitturi A; Patel J; Szankasi P; Morrissette JJD; Lim MS; Elenitoba-Johnson KSJ
    J Mol Diagn; 2023 Feb; 25(2):87-93. PubMed ID: 36503148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical Validation of an Automated Semiconductor-Based Next-Generation Sequencing Assay for Detection of DNA and RNA Alterations in Myeloid Neoplasms.
    Zbieranski N; Insuasti-Beltran G
    J Mol Diagn; 2024 Jan; 26(1):29-36. PubMed ID: 37879438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.
    Werner R; Connolly A; Bennett M; Hand CK; Burke L
    J Clin Pathol; 2024 Mar; 77(4):278-283. PubMed ID: 36522176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing Assay.
    Ferrone CK; Wong H; Semenuk L; Werunga B; Snetsinger B; Zhang X; Zhang G; Lui J; Richard-Carpentier G; Crocker S; Good D; Hay AE; Quest G; Carson N; Feilotter HE; Rauh MJ
    J Mol Diagn; 2021 Oct; 23(10):1292-1305. PubMed ID: 34365012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes.
    Izevbaye I; Liang LY; Mather C; El-Hallani S; Maglantay R; Saini L
    J Mol Diagn; 2020 Feb; 22(2):208-219. PubMed ID: 31751678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Evaluation of a Novel Nine-Gene Panel for Ion Torrent PGM Sequencing of Myeloid Malignancies.
    Ivanova M; Shivarov V; Pavlov I; Lilakos K; Naumova E
    Mol Diagn Ther; 2016 Feb; 20(1):27-32. PubMed ID: 26476543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion Torrent ™ Genexus ™ Integrated Sequencer and ForeNGS Analysis Software-An automatic NGS-STR workflow from DNA to profile for forensic science.
    Guo F; Lang Y; Long G; Liu Z; Jing G; Zhou Y; Zhang B; Yu S
    Forensic Sci Int Genet; 2022 Nov; 61():102753. PubMed ID: 35931007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
    Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of pathogenic mutations in Marfan syndrome by targeted next-generation semiconductor sequencing].
    Lu C; Wu W; Xiao J; Meng Y; Zhang S; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):301-4. PubMed ID: 23744319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
    Garofoli A; Paradiso V; Montazeri H; Jermann PM; Roma G; Tornillo L; Terracciano LM; Piscuoglio S; Ng CKY
    J Mol Diagn; 2019 Sep; 21(5):884-894. PubMed ID: 31229654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.
    Bhai P; Hsia CC; Schenkel LC; Hedley BD; Levy MA; Kerkhof J; Santos S; Stuart A; Lin H; Broadbent R; Nan S; Yang P; Xenocostas A; Chin-Yee I; Sadikovic B
    Mol Diagn Ther; 2022 May; 26(3):333-343. PubMed ID: 35381971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.
    Paasinen-Sohns A; Koelzer VH; Frank A; Schafroth J; Gisler A; Sachs M; Graber A; Rothschild SI; Wicki A; Cathomas G; Mertz KD
    Neoplasia; 2017 Mar; 19(3):196-206. PubMed ID: 28161563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
    Sahajpal NS; Mondal AK; Ananth S; Njau A; Ahluwalia P; Jones K; Ahluwalia M; Okechukwu N; Savage NM; Kota V; Rojiani AM; Kolhe R
    PLoS One; 2020; 15(10):e0240976. PubMed ID: 33075099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer.
    Low SK; Ariyasu R; Uchibori K; Hayashi R; Chan HT; Chin YM; Akita T; Harutani Y; Kiritani A; Tsugitomi R; Manabe R; Ogusu S; Amino Y; Kitazono S; Yanagitani N; Nakamura Y; Nishio M
    Transl Lung Cancer Res; 2022 May; 11(5):711-721. PubMed ID: 35693289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing-based panel testing for myeloid neoplasms.
    Kuo FC; Dong F
    Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishing the Ion Torrent PGM Sequencing Methods for the Clinical Diagnosis of MPN Patients].
    Huang JX; Li YL; Xu N; Yin CX; Zhou X; Pan CY; He BL; Lu ZY; Liu QF; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1744-1750. PubMed ID: 29262909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
    Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
    Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.